Should Biotechnology Stock Aileron Therapeutics Inc (ALRN) Be in Your Portfolio Friday?

Aileron Therapeutics Inc (ALRN) is around the top of the Biotechnology industry according to InvestorsObserver. ALRN received an overall rating of 58, which means that it scores higher than 58 percent of all stocks. Aileron Therapeutics Inc also achieved a score of 70 in the Biotechnology industry, putting it above 70 percent of Biotechnology stocks. Biotechnology is ranked 48 out of the 148 industries.

ALRN has an Overall Score of 58. Find out what this means to you and get the rest of the rankings on ALRN!

See Full ALRN Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 58 means the stock is more attractive than 58 percent of stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Aileron Therapeutics Inc Stock Today?

Aileron Therapeutics Inc (ALRN) stock has risen 27.36% while the S&P 500 is down -0.76% as of 3:15 PM on Friday, Dec 30. ALRN is up $0.51 from the previous closing price of $1.87 on volume of 133,099 shares. Over the past year the S&P 500 has fallen -20.07% while ALRN is down -77.78%. ALRN lost -$0.17 per share the over the last 12 months. Click Here to get the full Stock Report for Aileron Therapeutics Inc stock.